University of California San Francisco
Give to UCSFThe American Orthopaedic Society for Sports Medicine (AOSSM) and the Arthritis Foundation have awarded a $500,000 multicenter research grant to UCSF Health’s Michael Davies, MD, and co-principal investigators Brian Feeley, MD, of UCSF, and Robert Tashjian, MD, of the University of Utah, for a first-of-its-kind collaboration intended to advance research and treatment of osteoarthritis.
The vascular surgery team at UCSF Health recently became the first among University of California medical centers to implant a Barostim device to treat heart failure. The team implanted the device in a young woman with the goal of reducing her heart failure symptoms and improving her quality of life.
Barostim is a new, FDA-approved, implantable device that rebalances the autonomic nervous system, with the goal of improving outcomes for heart failure patients with reduced ejection fraction.